Dulaglutide
Established weekly GLP-1 agonist
Weight Losssubcutaneousany
Overview
Long-acting GLP-1 receptor agonist similar to semaglutide. Reduces appetite, improves glycaemic control, and supports cardiovascular health.
Dosing
- Typical Dosage
- 0.75-1.5 mg
- Frequency
- Weekly
- Cycle Duration
- Ongoing
- Administration
- subcutaneous
Available Vial Sizes
5mg10mg
FDA-approved as Trulicity. Good option for those who tolerate GLP-1s well.
Comprehensive Information
AI-GeneratedGenerating comprehensive analysis...
This may take a moment
Mechanism of Action
Key Benefits
Optimal Timing
Potential Side Effects
Stacking Suggestions
Practical Tips
Could not load AI-generated information
Track Your Dulaglutide Protocol
Join UpgradeYourself to track your peptide protocols, log injections with our interactive body map, and receive AI-powered insights tailored to your health goals.
Free forever planNo credit card required100+ peptides tracked